Stay updated on Semaglutide Efficacy in Diabetes & Obesity Clinical Trial
Sign up to get notified when there's something new on the Semaglutide Efficacy in Diabetes & Obesity Clinical Trial page.

Latest updates to the Semaglutide Efficacy in Diabetes & Obesity Clinical Trial page
- Check6 days agoChange DetectedLocations section updated with numerous new trial sites across the US, Canada, India, and other regions, and several existing sites removed; revision is labeled v3.3.3.SummaryDifference2%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedThe page shows a revision label updated from v3.3.1 to v3.3.2. There appear to be no visible changes to the study content beyond the version label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check35 days agoChange DetectedThe Publications section adds two explanatory lines about voluntary publication submissions and automatic PubMed sourcing, and the Revision tag is updated from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check42 days agoChange DetectedRemoved the government funding status banner from the page, eliminating a banner that previously noted potential delays in updates due to funding. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check56 days agoChange DetectedNo additions or deletions were detected; the page content appears unchanged.SummaryDifference0.2%

- Check85 days agoChange DetectedAdded a new scholarly reference and updated the revision from v3.0.2 to v3.2.0.SummaryDifference0.5%

Stay in the know with updates to Semaglutide Efficacy in Diabetes & Obesity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide Efficacy in Diabetes & Obesity Clinical Trial page.